يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Gianni C."', وقت الاستعلام: 0.67s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma

    المؤلفون: Gianni C., Bronte G., Delmonte A., Burgio M. A., Andrikou K., Monti M., Menna C., Frassineti G. L., Crino L.

    المساهمون: Gianni, C., Bronte, G., Delmonte, A., Burgio, M. A., Andrikou, K., Monti, M., Menna, C., Frassineti, G. L., Crino, L.

    مصطلحات موضوعية: liver toxicity, non-small cell lung cancer, osimertinib, pembrolizumab, stevens johnson syndrome

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34456717; info:eu-repo/semantics/altIdentifier/wos/WOS:000693876500001; volume:12; firstpage:672233; journal:FRONTIERS IN PHARMACOLOGY; http://hdl.handle.net/11566/297488Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85113776400

    الإتاحة: https://doi.org/10.3389/fphar.2021.672233Test
    http://hdl.handle.net/11566/297488Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma

    المؤلفون: Gianni C., Bronte G., Delmonte A., Burgio M. A., Andrikou K., Monti M., Menna C., Frassineti G. L., Crino L.

    المساهمون: Gianni, C., Bronte, G., Delmonte, A., Burgio, M. A., Andrikou, K., Monti, M., Menna, C., Frassineti, G. L., Crino, L.

    مصطلحات موضوعية: liver toxicity, non-small cell lung cancer, osimertinib, pembrolizumab, stevens johnson syndrome

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34456717; info:eu-repo/semantics/altIdentifier/wos/WOS:000693876500001; volume:12; firstpage:672233-1; lastpage:672233-6; numberofpages:6; journal:FRONTIERS IN PHARMACOLOGY; https://hdl.handle.net/11392/2542210Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85113776400; https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.672233/fullTest

    الإتاحة: https://doi.org/10.3389/fphar.2021.672233Test
    https://hdl.handle.net/11392/2542210Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma

    المؤلفون: Gianni C., Bronte G., Delmonte A., Burgio M. A., Andrikou K., Monti M., Menna C., Frassineti G. L., Crino L.

    المساهمون: Gianni, C., Bronte, G., Delmonte, A., Burgio, M. A., Andrikou, K., Monti, M., Menna, C., Frassineti, G. L., Crino, L.

    مصطلحات موضوعية: liver toxicity, non-small cell lung cancer, osimertinib, pembrolizumab, stevens johnson syndrome

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34456717; info:eu-repo/semantics/altIdentifier/wos/WOS:000693876500001; volume:12; firstpage:672233-1; lastpage:672233-6; numberofpages:6; journal:FRONTIERS IN PHARMACOLOGY; https://hdl.handle.net/11392/2542210Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85113776400; https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.672233/fullTest

    الإتاحة: https://doi.org/10.3389/fphar.2021.672233Test
    https://hdl.handle.net/11392/2542210Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث